Chelation in Metal Intoxication

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2010 Aug 19

PMID 20717537

Citations 215

Authors

Swaran J S Flora

Vidhu Pachauri

Affiliations

Soon will be listed here.

Abstract

Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals. Chelating agents are capable of binding to toxic metal ions to form complex structures which are easily excreted from the body removing them from intracellular or extracellular spaces. 2,3-Dimercaprol has long been the mainstay of chelation therapy for lead or arsenic poisoning, however its serious side effects have led researchers to develop less toxic analogues. Hydrophilic chelators like meso-2,3-dimercaptosuccinic acid effectively promote renal metal excretion, but their ability to access intracellular metals is weak. Newer strategies to address these drawbacks like combination therapy (use of structurally different chelating agents) or co-administration of antioxidants have been reported recently. In this review we provide an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications.

Citing Articles

Recent advances in the clinical management of intoxication by five heavy metals: Mercury, lead, chromium, cadmium and arsenic.

Balali-Mood M, Eizadi-Mood N, Hassanian-Moghaddam H, Etemad L, Moshiri M, Vahabzadeh M Heliyon. 2025; 11(4):e42696.

PMID: 40040983 PMC: 11876891. DOI: 10.1016/j.heliyon.2025.e42696.

CXCL12 as a Potential Hub Gene for N-Acetylcysteine Treatment of T1DM Liver Disease.

Zhao M, Han M, Guo S, Tang Z Biomolecules. 2025; 15(2).

PMID: 40001479 PMC: 11853168. DOI: 10.3390/biom15020176.

Environmental problems of emerging toxic metals and treatment technology and methods.

Zhang Y, Shen Z, Zhou W, Liu C, Li Y, Ding B RSC Adv. 2024; 14(50):37299-37310.

PMID: 39588236 PMC: 11586922. DOI: 10.1039/d4ra06085g.

Heavy Metals in Umbilical Cord Blood: Effects on Epigenetics and Child Development.

Dutta S, Ruden D Cells. 2024; 13(21).

PMID: 39513881 PMC: 11544782. DOI: 10.3390/cells13211775.

Exploring the Physicochemical Characteristics of Marine Protein Hydrolysates and the Impact of In Vitro Gastrointestinal Digestion on Their Bioactivity.

Sharma D, Gite S, Tuohy M Mar Drugs. 2024; 22(10).

PMID: 39452860 PMC: 11509636. DOI: 10.3390/md22100452.

References

Waisberg M, Joseph P, Hale B, Beyersmann D . Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology. 2003; 192(2-3):95-117. DOI: 10.1016/s0300-483x(03)00305-6. View

Jones M, Singh P, GALE G, Atkins L, Smith A . Esters of meso-dimercaptosuccinic acid as cadmium-mobilizing agents. Toxicol Appl Pharmacol. 1988; 95(3):507-14. DOI: 10.1016/0041-008x(88)90369-9. View

Kodama H, Murata Y, Iitsuka T, Abe T . Metabolism of administered triethylene tetramine dihydrochloride in humans. Life Sci. 1997; 61(9):899-907. DOI: 10.1016/s0024-3205(97)00592-4. View

Graziano J . Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol. 1986; 1(3):155-62. DOI: 10.1007/BF03259834. View

Mehta A, Kannan G, Dube S, Pant B, Pant S, Flora S . Haematological, hepatic and renal alterations after repeated oral or intraperitoneal administration of monoisoamyl DMSA. I. Changes in male rats. J Appl Toxicol. 2002; 22(6):359-69. DOI: 10.1002/jat.871. View

Gersl V, Hrdina R, Vavrova J, Holeckova M, Palicka V, Voglova J . Effects of repeated administration of dithiol chelating agent--sodium 2,3-dimercapto-1-propanesulphonate (DMPS)--on biochemical and haematological parameters in rabbits. Acta Medica (Hradec Kralove). 1997; 40(1):3-8. View

Blanusa M, Varnai V, Piasek M, Kostial K . Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem. 2005; 12(23):2771-94. DOI: 10.2174/092986705774462987. View

Singh S, Khodr H, Taylor M, Hider R . Therapeutic iron chelators and their potential side-effects. Biochem Soc Symp. 1995; 61:127-37. DOI: 10.1042/bss0610127. View

Flora S, Bhattacharya R, Sachan S . Dose-dependent effects of zinc supplementation during chelation of lead in rats. Pharmacol Toxicol. 1994; 74(6):330-3. DOI: 10.1111/j.1600-0773.1994.tb01368.x. View

10.

Hartwig A, Schlepegrell R, Beyersmann D . Cellular damage by ferric nitrilotriacetate and ferric citrate in V79 cells: interrelationship between lipid peroxidation, DNA strand breaks and sister chromatid exchanges. Carcinogenesis. 1993; 14(1):107-12. DOI: 10.1093/carcin/14.1.107. View

11.

Nagasaki H, Nakano H, Boudjema K, Jaeck D, Alexandre E, Baek Y . Efficacy of preconditioning with N-acetylcysteine against reperfusion injury after prolonged cold ischaemia in rats liver in which glutathione had been reduced by buthionine sulphoximine. Eur J Surg. 1998; 164(2):139-46. DOI: 10.1080/110241598750004805. View

12.

Andersen O . Chemical and biological considerations in the treatment of metal intoxications by chelating agents. Mini Rev Med Chem. 2004; 4(1):11-21. DOI: 10.2174/1389557043487583. View

13.

Watanabe M, Henmi K, Ogawa K, Suzuki T . Cadmium-dependent generation of reactive oxygen species and mitochondrial DNA breaks in photosynthetic and non-photosynthetic strains of Euglena gracilis. Comp Biochem Physiol C Toxicol Pharmacol. 2003; 134(2):227-34. DOI: 10.1016/s1532-0456(02)00253-3. View

14.

Miller K, Liebowitz R, Newby L . Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J. 2004; 147(3):401-11. DOI: 10.1016/j.ahj.2003.10.021. View

15.

Flora S . Lead exposure: health effects, prevention and treatment. J Environ Biol. 2003; 23(1):25-41. View

16.

Shaikh Z, Zaman K, Tang W, Vu T . Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteine. Toxicol Lett. 1999; 104(1-2):137-42. DOI: 10.1016/s0378-4274(98)00358-0. View

17.

Peters R, STOCKEN L, THOMPSON R . British anti-lewisite (BAL). Nature. 2010; 156:616-9. DOI: 10.1038/156616a0. View

18.

Tenenbein M . Hepatotoxicity in acute iron poisoning. J Toxicol Clin Toxicol. 2002; 39(7):721-6. DOI: 10.1081/clt-100108513. View

19.

Risher J, Nickle R, Amler S . Elemental mercury poisoning in occupational and residential settings. Int J Hyg Environ Health. 2003; 206(4-5):371-9. DOI: 10.1078/1438-4639-00233. View

20.

Flora S . Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin Exp Pharmacol Physiol. 1999; 26(11):865-9. DOI: 10.1046/j.1440-1681.1999.03157.x. View